HATC
HATC is a HIF-1α AUTAC degrader. HATC links HIF-1α to LC3 to form a ternary complex that undergoes degradation via the autophagy-lysosome fusion pathway. HATC induces dose-dependent HIF-1α degradation in multiple cell types. HATC reduces visceral fat accumulation, hepatic lipid deposition, senescent cell aggregation, and bone loss; alleviates age-related intervertebral disc degeneration, liver dysfunction, kyphosis, and alveolar dilation; decreases circulating lactic acid levels; improves physical performance; and reverses age-related changes in granulocyte proportions. HATC extends median and maximum lifespan, reduces transcriptomic age, and causes no obvious persistent toxicity. HATC can be used in the research of age-related diseases (pink: LC3 ligand (HY-50759); blue: HIF-1α ligand (HY-P10426); Linker: (HY-W008264)).
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Formule: C79H102ClN13O13
- Masse moléculaire:1477.19
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
IC50 & Target
[1]|
HIF-1α |
In Vitro
HATC (1-2 μM) potently induces autophagic degradation of HIF-1α in NP cells at 5% oxygen with no cytotoxicity at concentrations up to 2 μM[1].
HATC induces autophagic degradation of HIF-1α in 293T and HeLa cells under hypoxic conditions[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Parmacokinetics
| Species | Dose | Route | Plasma Concentration |
|---|---|---|---|
| Mice[1] | 20 mg/kg | i.p. | 0.3 μM |
In Vivo
HATC (20 mg/kg; i.p.; once weekly) reduces HIF-1α levels and alleviates lumbar spine instability-induced accelerated intervertebral disc aging in mice[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:C57BL/6J mice (male and female, aged 20 months at treatment initiation)[1]
-
Dosage:20 mg/kg
-
Administration:i.p.; once weekly; until natural death
-
Result:Extended median lifespan by 14% and maximum lifespan by 12.1% compared to vehicle.
Mitigated age-associated weight gain and prevented rapid terminal weight loss, maintaining stable body weight until late life.
Reduced HIF-1α levels across multiple organs (lung, spleen, liver) compared to vehicle-treated aged mice.
Lowered predicted transcriptomic age in 24-month-old mice, with transcriptomic changes showing upregulation of pathways linked to improved organ function and metabolic health.
Reduced abdominal visceral fat accumulation and hepatic lipid deposition, prevented age-related increases in serum alanine aminotransferase and aspartate aminotransferase levels, and lowered circulating lactate levels to near young-mouse levels.
Improved multiple physical performance metrics (grip strength, maximal walking speed, bean balance time, hanging endurance, daily activity) to values approaching young mice.
Reduced age-related bone mass loss in female mice, improved spinal kyphosis index (lower spinal curvature), and attenuated age-dependent alveolar volume expansion in the lungs.
Reduced P16INK4a-positive senescent cells in organs, decreased inflammatory cell invasion in lung and liver, lowered circulating levels of SASP markers (IL-6, G-CSF), and reversed age-related increases in granulocyte proportion.
Reduced spontaneous tumor incidence by ~20% compared to vehicle-treated mice.
-
Animal Model:mice (aged 9 months at treatment initiation, LSI-induced aging model)[1]
-
Dosage:20 mg/kg
-
Administration:i.p.; once weekly; 3 months
-
Result:Significantly reduced HIF-1α levels in IVDs within 2 weeks of treatment initiation.
Alleviated age-related disc degeneration, as shown by improved histological scores on Safranin O/Fast Green staining, higher T2-weighted MRI signal intensity in IVDs, increased paw withdrawal threshold (reduced low back pain), and reduced P16INK4a-positive senescent cell accumulation in IVDs compared to vehicle-treated LSI mice.
Caused no overt toxicity or tissue damage in major organs (lung, spleen, liver) as assessed by H&E staining.
Chemical Information
-
Masse moléculaire 1477.19
-
Formule C79H102ClN13O13
-
SMILES
O=C1N(CC2=CC=CC=C2)C([C@@H](C(C)C)N(CCCNC(CCOCCOCCOCCN3C=C(C[C@H](NC([C@H](CC4=CC=C(O)C=C4)N5)=O)C(N[C@@H](CC(C)C)C(N[C@@H](CC(C)C)C(N[C@@H](CC6=CC=CC=C6)C(N[C@@H](C(C)C)C5=O)=O)=O)=O)=O)N=N3)=O)C(C7=CC=C(C)C=C7)=O)=NC8=CC(Cl)=CC=C18
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocole
-
Autophagy
Autophagy is a process in which eukaryotic cells use lysosomes to degrade their own cytoplasmic proteins and damaged organelles under the regulation of autophagy related gene (Atg). Microtubule-associated proteins light chain 3 (LC3) is recognized as autophagy marker, which transfers from cytoplasmic LC3 (LC3-I) to membrane type (LC3-II). LC3-II/I ratio could be detected by Western Blot and fluorescence microscopy.
-
Suspension Spheroid Formation (Low-Adhesion/Forced Aggregation)
Suspension spheroid formation by low-adhesion or forced aggregation is a scaffold-free 3D culture method in which cells are prevented from attaching to plastic and are guided to interact with each other, forming compact multicellular aggregates through cell-cell adhesion, gravity-driven settling, microwell confinement, or centrifugation-assisted aggregation. The method detects the capacity of a cell population to self-assemble into spheroids, and the main readouts are spheroid formation efficiency, morphology, compactness, projected area or diameter, circularity, viability, proliferation, and experimental responses such as drug sensitivity. Classic implementations include hanging drops, agarose or hydrogel microwells, ultra-low-attachment round-bottom wells, and centrifugation-assisted aggregation in non-adherent wells. Low-adhesion culture shifts the system away from cell-substrate adhesion and toward cell-cell adhesion, while round-bottom or microwell geometry concentrates cells into
-
Hanging Drop Spheroid Culture
Hanging drop spheroid culture is a scaffold-free 3D culture method in which a small droplet of cell suspension is inverted so that suspended cells sediment by gravity toward the lowest point of the drop, aggregate, and form a multicellular spheroid with direct cell-cell contact. Spheroids generated by this method are used to study 3D cell cohesion, cell-ECM interactions, drug response, co-culture organization, and tumor-like microenvironmental behavior. The primary readouts are spheroid formation efficiency, spheroid size, circularity or compactness, viability, and treatment response; these can be measured by bright-field microscopy, fluorescence viability staining, ATP-, fluorescence-, or colorimetric-based assays, and image-based diameter or volume calculations.
-
Lysosome and acidic-vesicle live-cell staining
Lysosome and acidic-vesicle live-cell staining detects acidic intracellular compartments by using membrane-permeant acidotropic probes that accumulate in low-pH vesicles, including lysosomes, late endosomes, autolysosomes, and acidic phagosomes. LysoTracker staining is commonly used as an intensity-based readout of acidic lysosomal compartment abundance or enlargement, while acridine orange produces green fluorescence in less concentrated compartments and red fluorescence after concentration-dependent accumulation in acidic vesicular organelles. Loss or reduction of acridine-orange red signal can be used as a readout of lysosomal membrane permeabilization or reduced acidic-vesicle integrity. This protocol is designed for live cultured cells and can be adapted for fluorescence microscopy, high-content imaging, plate-reader readout, or flow cytometry when the selected literature supports the readout. Because these dyes report acidotropic accumulation rather than lysosome identity alone,
-
Macroautophagy Solutions
Macroautophagy is a conserved lysosome-dependent degradation pathway in which cytoplasmic material is sequestered into double-membrane autophagosomes and delivered to lysosomes for degradation and recycling. The pathway supports cellular homeostasis during nutrient limitation, organelle stress, protein-aggregate accumulation, infection, differentiation, and tissue remodeling by coupling cargo sequestration, autophagosome maturation, lysosomal fusion, and degradation of cargo-derived macromolecules. The core molecular sequence includes initiation by nutrient- and stress-regulated autophagy machinery, autophagosome nucleation, LC3/ATG8-family conjugation to autophagosomal membranes, cargo selection through receptors such as SQSTM1/p62, autophagosome-lysosome fusion, and lysosomal degradation. LC3 was identified as a mammalian homolog of yeast Atg8 that localizes to autophagosomal membranes after processing, and p62/SQSTM1 was shown to connect ubiquitinated cargo with autophagic degradati
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)